Head-To-Head Analysis: BioLife Solutions (NASDAQ:BLFS) and Glucose Health (OTCMKTS:GLUC)

Glucose Health (OTCMKTS:GLUC) and BioLife Solutions (NASDAQ:BLFS) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, valuation, risk, dividends, profitability and analyst recommendations.

Institutional & Insider Ownership

93.2% of BioLife Solutions shares are owned by institutional investors. 2.2% of BioLife Solutions shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Analyst Ratings

This is a breakdown of current ratings and recommmendations for Glucose Health and BioLife Solutions, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Glucose Health	0	0	0	0	0.00
BioLife Solutions	1	1	4	0	2.50

BioLife Solutions has a consensus price target of $30.75, suggesting a potential upside of 26.08%. Given BioLife Solutions’ stronger consensus rating and higher probable upside, analysts clearly believe BioLife Solutions is more favorable than Glucose Health.

Risk & Volatility

Glucose Health has a beta of 1.59, meaning that its stock price is 59% more volatile than the S&P 500. Comparatively, BioLife Solutions has a beta of 1.93, meaning that its stock price is 93% more volatile than the S&P 500.

Valuation & Earnings

This table compares Glucose Health and BioLife Solutions”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Glucose Health	$380,000.00	6.39	-$320,000.00	($0.03)	-4.34
BioLife Solutions	$82.25 million	14.28	-$20.18 million	($0.07)	-348.43

Glucose Health has higher earnings, but lower revenue than BioLife Solutions. BioLife Solutions is trading at a lower price-to-earnings ratio than Glucose Health, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Glucose Health and BioLife Solutions’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Glucose Health	N/A	N/A	N/A
BioLife Solutions	-3.20%	0.97%	0.87%

Summary

BioLife Solutions beats Glucose Health on 10 of the 14 factors compared between the two stocks.

About Glucose Health

Glucose Health, Inc. engages in the formulation, manufacturing, marketing, and distribution of soluble fiber infused nutritional beverages. It offers soluble fiber infused powdered iced tea, and flavored drink mixes for pre-diabetic and diabetic persons under the GLUCODOWN brand in North America. The company was formerly known as Bio-Solutions Corp. and changed its name to Glucose Health, Inc. in November 2014. Glucose Health, Inc. was incorporated in 2007 and is based in Bentonville, Arkansas.

About BioLife Solutions

BioLife Solutions, Inc. develops, manufactures, and markets bioproduction tools and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company’s products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor Freeze Media that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; bioproduction tools, such as human platelet lysates for cell expansion and CellSeal closed system vials that are used in CGT; and the ThawSTAR line that comprises of a family of automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags. The company also provides cryogenic freezer technology for controlled rate freezing and cryogenic storage of biologic materials; ultra-low temperature mechanical freezers; evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals; liquid nitrogen laboratory freezers, cryogenic equipment, and accessories; and biological and pharmaceutical storage and transport services. It markets and sells its products directly, as well as through third party distributors. The company was incorporated in 1987 and is headquartered in Bothell, Washington.